At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD certified and US-FDA cleared.
Looking for a particular Q-linea employee's phone or email?
The Q-linea annual revenue was $17.5 million in 2026.
Stuart Gander is the President and CEO of Q-linea.
64 people are employed at Q-linea.
Q-linea is based in Uppsala, Uppsala.
The NAICS codes for Q-linea are [32, 3254, 325, 32541, 325413].
The SIC codes for Q-linea are [28, 283].